Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by malibukion Oct 19, 2018 5:39am
99 Views
Post# 28832735

new wingman

new wingman

Trying to conclude just around the corner deal for more than 5 years and now understanding that you need someone to guide in Japan. Wow, really smart move. These are red flags, many came to consult before and nothing came out. Why would it be different now?

They just need to conclude anything that would give us some confidence. It could be in Malta, Cyprus whatever. Show us that all this drama is real.

None of the previously interested partners came up with a solid support for 1067. This bothers me a lot. If 1067 is so good, why did it take that long to conclude a single deal even in a small market?

Unless we see trial results, there is a big question mark (I hope they are smart enough to compare their product with one of the commonly used stuff. Otherwise even if you use orange juice you can say "Well there is a slight bleaching.") Prove us this is the best -or very good- skin lightner, not "Yea it may help" type of product.

At the end science writes the story, the rest is just details.

Bullboard Posts